Corneal thickness affects glaucoma severity

Article

Thinner corneas could be linked to higher glaucoma severity.

Thinner corneas could be linked to higher glaucoma severity, claims a paper in the journal Eye.

Dr M. Iester et al., Clinica Oculistica, University of Siena, Siena, Italy, included 816 glaucoma patients from 16 various glaucoma centres. The outcome measures were CCT, ophthalmoscopic cup/disc ratio, mean deviation (MD), pattern SD (PSD) and IOP. The difference between paired eyes was calculated for all parameters. Three different CCT cutoffs, 10, 15, and 20 μm, were chosen.

The 20 μm subgroup demonstrated no significant difference in IOP between the paired eyes. However, there was a significant difference in MD, PSD and cup/disc ratio. There were nosignificant differences between CCT and the remaining parameters.

It was concluded that CCT between the two eyes could be linked to a more severe glaucoma in the eye with the thinner cornea.

Please click here to read the abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.